MedTrace Logo

Diphenhydramine in Catheter Related Bladder Discomfort

NCT06345261 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2024-04-03

No results posted yet for this study

Summary

Diphenhydramine has H1-antihistamine action, it also possesses anti-muscarinic properties. Thus, diphenhydramine might be able to reduce the problem of catheter related bladder discomfort by inhibiting smooth muscle spasm of the urinary bladder via its anti-muscarinic action .

Conditions

  • Catheter Complications

Interventions

DRUG

DiphenhydrAMINE 50 Mg/mL Injectable Solution

injection of Diphenhydramine 50 Mg/mL

DRUG

Saline

injection of saline

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Amr s wahdan, MD · Cairo university , Cairo, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2025-04-01
Completion
2025-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06345261 on ClinicalTrials.gov